טוען...
The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension
1 In a double-blind, placebo controlled, crossover study 12 patients with essential hypertension received single doses of 5, 10 and 20 mg of cilazapril. 2 Peak plasma levels of cilazaprilat and the 24 h areas under curve were directly proportional to dose. 3 The elimination half-life during the firs...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
1989
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1379756/ https://ncbi.nlm.nih.gov/pubmed/2548553 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|